Validation of a French-version of the Leeds Food Preference Questionnaire in Normal Weight and Patients With Obesity (LFPQ-F)

February 16, 2022 updated by: University Hospital, Clermont-Ferrand

While Food reward is an important component of the appetite control to consider, there is actually no tool that has been developed in French to perform its evaluation.

The Leeds Food Preference Questionnaire (LFPQ) is a validated and recognized tool to assess food reward, being however developed for British populations.

The aim of this work is to validate a French version of the LFPQ among lean and obese adults.

Study Overview

Status

Terminated

Detailed Description

50 lean and 50 patients with obesity between 20 and 55 years old (50% women and 50% men), will be recruited. After an evaluation of their body composition by impedance meter, and of their dietary status by questionnaires (TFEQ/DEBQ), they will be asked to perform twice the same experimental sessions. They will be asked during this session to arrive at 08:00 am after a 12-hour fast and will receive a calibrated breakfast. Before and after a lunch calibrated meal, they will be asked to perform the French version of the computerized questionnaire LFPQ. Appetite feelings will be assessed at regular intervals.

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • Chu Clermont Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 30 and 38 kg.m² for the obese patients and 20 and 25 for the lean ones.
  • registered to the national social security system
  • Signed consent

Exclusion Criteria:

  • eating disorders
  • metabolic disease such as hypertension and Type 2 diabetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: NW (Normal Weight)
20 to 55 years old lean adults
the participants will fill in the LFPQ questionnaire before and after a lunch test meal
this is a replication of Visit 1, testing the reproducibility of the LFPQ and of its response to a meal.
EXPERIMENTAL: OBESE
20 to 55 years old adults with obesity
the participants will fill in the LFPQ questionnaire before and after a lunch test meal
this is a replication of Visit 1, testing the reproducibility of the LFPQ and of its response to a meal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Food reward
Time Frame: day 1 , day 8
The participants will be asked to complete the developed French version of the computer-based procedure to measure food reward (Leeds Food Preference Questionnaire; LFPQ) (Finlayson, King et al. 2008).
day 1 , day 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body fat mass
Time Frame: day 0
the percentage of body fat and the quantity of fat mass will be assessed using Bio-impedance (BIA)
day 0
Body fat and fat free mass
Time Frame: day 0
the percentage of body fat free and the quantity of fat free mass will be assessed using Bio-impedance (BIA)
day 0
Dietary status
Time Frame: day 0
the level of dietary restriction/disinhibition will be assessed using the TFEQ questionnaire.
day 0
Dietary status
Time Frame: day 0
the level of dietary restriction/disinhibition will be assessed using the DEBQ questionnaire.
day 0
Hunger
Time Frame: day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
the hunger sensation will be assessed using visual analogue scales of 150 mm.
day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
Satiety
Time Frame: dday 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
the Satiety sensation will be assessed using visual analogue scales of 150 mm.
dday 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
desire to eat
Time Frame: day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
the desire to eat sensation will be assessed using visual analogue scales of 150 mm.
day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
Prospective Food consumption
Time Frame: day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes
the Prospective Food consumption sensation will be assessed using visual analogue scales of 150 mm.
day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 8, 2019

Primary Completion (ACTUAL)

June 25, 2021

Study Completion (ACTUAL)

June 25, 2021

Study Registration Dates

First Submitted

July 29, 2019

First Submitted That Met QC Criteria

July 31, 2019

First Posted (ACTUAL)

August 1, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 4, 2022

Last Update Submitted That Met QC Criteria

February 16, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2019 GENTES
  • 2019-A00853-54 (OTHER: 2019-A00853-54)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Normal Weight Adults

Clinical Trials on Visit 1

Subscribe